| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |